| ［1］ |
陈晶晶, 苏玉华, 施辛, 等. 重症药疹严重程度评价系统（二）［J］. 实用皮肤病学杂志, 2019,12（4）:219⁃222. doi: 10.11786/sypfbxzz.1674⁃1293.20190408.
|
| ［2］ |
Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens⁃Johnson syndrome and toxic epidermal necrolysis: comparison with case⁃control analysis［J］. Clin Pharmacol Ther, 2010,88（1）:60⁃68. doi: 10.1038/clpt.2009.252.
|
| ［3］ |
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions［J］. Clin Pharmacol Ther, 1981,30（2）:239⁃245. doi: 10.1038/clpt.1981.154.
|
| ［4］ |
Vivar KL, Deschaine M, Messina J, et al. Epidermal programmed cell death⁃ligand 1 expression in TEN associated with nivolumab therapy［J］. J Cutan Pathol, 2017,44（4）:381⁃384. doi: 10.1111/cup.12876.
|
| ［5］ |
Logan IT, Zaman S, Hussein L, et al. Combination therapy of ipilimumab and nivolumab⁃associated toxic epidermal necrolysis （TEN） in a patient with metastatic melanoma: a case report and literature review［J］. J Immunother, 2020,43（3）:89⁃92. doi: 10.1097/CJI.0000000000000302.
|
| ［6］ |
Nayar N, Briscoe K, Fernandez Penas P. Toxic epidermal necrolysis⁃like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma［J］. J Immunother, 2016,39（3）:149⁃152. doi: 10.1097/CJI.0000000000000112.
|
| ［7］ |
Basu P, Tong Y, Hinds BR, et al. Nivolumab⁃induced toxic epidermal necrolysis with retiform purpura［J/OL］. Br J Dermatol, 2020,183（2）:e32. doi: 10.1111/bjd.19031.
|
| ［8］ |
Griffin LL, Cove⁃Smith L, Alachkar H, et al. Toxic epidermal necrolysis （TEN） associated with the use of nivolumab （PD⁃1 inhibitor） for lymphoma［J］. JAAD Case Rep, 2018,4（3）:229⁃231. doi: 10.1016/j.jdcr.2017.09.028.
|
| ［9］ |
Watanabe Y, Yamaguchi Y, Takamura N, et al. Toxic epidermal necrolysis accompanied by several immune⁃related adverse events developed after discontinuation of nivolumab［J］. Eur J Cancer, 2020,131:1⁃4. doi: 10.1016/j.ejca.2020.02.044.
|
| ［10］ |
陆晓君, 经晶, 施辛, 等. 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗中毒性表皮坏死松解症的临床疗效观察［J］. 中华皮肤科杂志, 2020,53（6）:428⁃434. doi: 10.35541/cjd.2020 0068.
|
| ［11］ |
Dudnik E, Moskovitz M, Daher S, et al. Effectiveness and safety of nivolumab in advanced non⁃small cell lung cancer: the real⁃life data［J］. Lung Cancer, 2018,126:217⁃223. doi: 10.1016/j.lungcan.2017.11.015.
|
